ArticleFrontiers in immunology2023

Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study.

Roberto Alfonso-Dunn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.